In vitro gene manipulation of spinal muscular atrophy fibroblast cell line using gene-targeting fragment for restoration of SMN protein expression

Gene Therapy
A RashnonejadF Özkınay

Abstract

The reduced level of survival motor neuron (SMN) protein, caused by homozygous deletions in the SMN gene, led to a common neurodegenerative disorder known as spinal muscular atrophy (SMA). In spite of extensive efforts to find a cure for SMA, there is currently no effective treatment available for this devastating disease. In this study, restoration of SMN expression through 'gene-targeting' method in SMA fibroblast cells was attempted. We designed a 2697-bp gene-targeting cassette; it consisted of an SMN1 open reading frame expressing 38 kD SMN protein and the upstream and downstream regions of exon 1 of SMN1 gene at the ends as the homology arms. SMA fibroblast cells were transfected by gene-targeting cassette using Lipofectamine LTX-PLUS reagent. Occurrence of homologous recombination in selected cells was investigated by PCR analysis. Increased expression of SMN protein was shown by real-time PCR and western blotting analysis. The immunofluorescence analysis results demonstrated that the number of SMN nuclear structures, Gems, was the same as or greater than the number of Gems found in normal fibroblasts. The results of this study indicate that gene-targeting methods do, in fact, present as an alternative for restoration of...Continue Reading

References

Jan 1, 1992·Neuromuscular Disorders : NMD·T L Munsat, K E Davies
Apr 26, 1980·Lancet·J Pearn
Jun 5, 1983·Journal of Molecular Biology·D Hanahan
Oct 21, 1999·Molecular Genetics and Metabolism·V A Lanzov
Jul 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sibylle JablonkaMichael Sendtner
Dec 16, 2004·The Journal of Clinical Investigation·Mimoun AzzouzNicholas D Mazarakis
Jan 22, 2005·Trends in Biotechnology·Alexander A VolodinR Daniel Camerini-Otero
May 24, 2005·Gene Therapy·D A DeanW E Zimmer
Jun 1, 2005·Biotechnology Advances·David A Sorrell, Andreas F Kolb
Aug 9, 2005·Biochemical and Biophysical Research Communications·Mala ManiSrinivasan Chandrasegaran
Apr 4, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Travis BaughanChristian L Lorson
May 6, 2006·Biochemical and Biophysical Research Communications·H KhanahmadS Zeinali
Dec 15, 2007·Experimental Cell Research·Darlise DiMatteoEric B Kmiec
Dec 23, 2008·Nature Biotechnology·Kevin D FoustBrian K Kaspar
Mar 5, 2010·Gene Therapy·A P Lam, D A Dean
Mar 18, 2010·The Journal of Clinical Investigation·Marco A PassiniSeng H Cheng
Apr 15, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jon P ConnellyMatthew H Porteus
Apr 16, 2010·Human Molecular Genetics·Christian L LorsonMonir Shababi
Jun 2, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kazim H Narsinh, Joseph C Wu
Dec 2, 2010·Human Molecular Genetics·Elisa DominguezMartine Barkats
Dec 21, 2012·Science Translational Medicine·Stefania CortiGiacomo P Comi
Jan 9, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sofia Benkhelifa-ZiyyatMartine Barkats
Oct 26, 2013·Nature Protocols·F Ann RanFeng Zhang
Apr 5, 2014·PLoS Genetics·Yinan KanEric A Hendrickson
May 23, 2014·Human Gene Therapy·Pádraig J MulcahyMimoun Azzouz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.